Odey Asset Management Group’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-33,800
Closed -$5.82M 73
2021
Q3
$5.82M Buy
+33,800
New +$4.42M 1.55% 15

Odey Asset Management Group's XLRN Position: Q4 2021 in Review

Odey Asset Management Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 33,800 shares — an estimated $5.82M sold.

Odey Asset Management Group first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $5.82M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Odey Asset Management Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Odey Asset Management Group sold 33,800 Acceleron Pharma shares in Q4 2021, an estimated $5.82M.
  • Odey Asset Management Group first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Odey Asset Management Group's Acceleron Pharma position peaked at $5.82M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Odey Asset Management Group's 13F filing for Q4 2021, filed 14 Feb 2022.